Capricor Therapeutics, Inc. (CAPR) Earnings History
Annual and quarterly earnings data from 1999 to 2024
Loading earnings history...
CAPR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CAPR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -124.4% | -191.1% | -181.7% |
| 2023 | -44.8% | -95.6% | -88.5% |
| 2022 | -755.1% | -1163.9% | -1137.4% |
| 2021 | 100.0% | -8549.9% | -8175.9% |
| 2020 | 100.0% | -4412.6% | -4401.9% |
Download Data
Export CAPR earnings history in CSV or JSON format
Free sign-in required to download data
Capricor Therapeutics, Inc. (CAPR) Earnings Overview
As of May 8, 2026, Capricor Therapeutics, Inc. (CAPR) reported trailing twelve-month net income of -$82M, reflecting -38.6% year-over-year growth. The company earned $-1.79 per diluted share over the past four quarters, with a net profit margin of -181.7%.
Looking at the long-term picture, CAPR's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 2017.
Capricor Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SRPT ($65M net income, -32.5% margin), CRSP (-$569M net income, -16569.8% margin), EXEL ($833M net income, 33.7% margin), CAPR has room to improve margins relative to the peer group. Compare CAPR vs SRPT →
CAPR Earnings vs Peers
Earnings metrics vs comparable public companies
CAPR Historical Earnings Data (1999–2024)
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$40M | -81.6% | -$43M | $-1.15 | -181.7% | -191.1% |
| 2023 | -$22M | +23.2% | -$24M | $-0.83 | -88.5% | -95.6% |
| 2022 | -$29M | -44.9% | -$30M | $-1.18 | -1137.4% | -1163.9% |
| 2021 | -$20M | -46.6% | -$21M | $-0.87 | -8175.9% | -8549.9% |
| 2020 | -$14M | -78.7% | -$14M | $-0.88 | -4401.9% | -4412.6% |
| 2019 | -$8M | +49.7% | -$8M | $-2.06 | -760.4% | -769.5% |
| 2018 | -$15M | -724.9% | -$15M | $-5.17 | -909.1% | -917.2% |
| 2017 | $2M | +112.9% | -$13M | $0.90 | 91.2% | -482.4% |
| 2016 | -$19M | -46.3% | -$17M | $-10.14 | -589.6% | -532.2% |
| 2015 | -$13M | -106.8% | -$13M | $-8.09 | -340.5% | -334.0% |
See CAPR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CAPR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CAPR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCAPR — Frequently Asked Questions
Quick answers to the most common questions about buying CAPR stock.
Is CAPR growing earnings?
CAPR EPS fell to $-1.79, with earnings declining -38.6%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-82M.
What are CAPR's profit margins?
Capricor Therapeutics, Inc. net margin is -181.7%, with operating margin at -191.1%. Below-average margins reflect competitive or cost pressures.
How consistent are CAPR's earnings?
CAPR earnings data spans 1999-2024. The declining earnings trend is -38.6% YoY. Historical data enables comparison across business cycles.